- Home
- / CABIO Biotech (Wuhan)
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
CABIO Biotech (Wuhan) financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
¥20.9
2024-10-29
Market Capitalization
¥3.5 B
2024-10-29
Revenue
¥541.6 M
FY, 2025
CreditSafe Score
?
Score changed on Jun 08, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| CNY | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 278.7M | 306.2M | 318.7M | 345.8M | 397.5M | 429.0M | 536.8M | 541.6M |
| Cost of goods sold | 146.1M | 146.5M | 145.5M | 175.3M | 250.8M | 255.6M | 313.3M | 294.5M |
| Gross profit | 133.8M | 160.0M | 173.4M | 170.8M | 178.1M | 181.8M | 236.9M | 262.6M |
| Gross profit margin, % | 48.0% | 52.2% | 54.4% | 49.4% | 44.8% | 42.4% | 44.1% | 48.5% |
| Operating expense total | 20.1M | 31.5M | 36.0M | 48.3M | 96.5M | 45.8M | 65.4M | 53.0M |
| Depreciation and amortization | 27.8M | 29.0M | 26.0M | 23.3M | 26.0M | 47.1M | 55.6M | 61.5M |
| EBITDA | 113.7M | 127.4M | 137.3M | 121.0M | 74.8M | 133.9M | 172.2M | 208.6M |
| EBITDA margin, % | 40.8% | 41.6% | 43.1% | 35.0% | 18.8% | 31.2% | 32.1% | 38.5% |
| EBIT | 112.3M | 139.1M | 143.3M | 138.3M | 61.1M | 92.3M | 134.1M | 157.9M |
| EBIT margin, % | 40.3% | 45.4% | 45.0% | 40.0% | 15.4% | 21.5% | 25.0% | 29.2% |
| Interest income | 475.0K | 987.0K | 3.9M | 7.0M | 5.4M | 2.1M | 1.9M | 2.1M |
| Interest expense | 11.0K | 351.0K | 366.0K | 595.0K | 398.0K | 1.7M | ||
| Pre tax profit | 113.8M | 139.7M | 157.7M | 152.1M | 78.1M | 100.0M | 139.8M | 162.3M |
| Income tax expense | 16.0M | 20.0M | 22.8M | 20.8M | 16.6M | 13.6M | 19.7M | 23.0M |
| Net Income | 97.8M | 119.8M | 134.9M | 131.3M | 61.6M | 86.4M | 120.1M | 139.3M |